Bladder cancer is the sixth most commonly diagnosed cancer in the United States. More than 90% of bladder cancers are urothelial carcinomas, cancers that arise in cells that line the bladder.

The latest study, titled “A global perspective on coal-fired power plants and burden of lung cancer,” published in the journal Environmental Health, looked at data from 13,581 coal-fired plants in 83 ...

Daraxonrasib and elraglusib significantly extended survival time for people with hard-to-treat metastatic disease.

A cancer diagnosis of any kind was linked to a nearly 40 percent increase in risk for shingles compared with the risk of someone without cancer. What’s more, people who had a blood-related cancer ...

A patient-first guide inspired by insights from the BeOne Patient Advocacy AI Innovation Lab Artificial intelligence (AI) is reshaping cancer care. More than 40 million people globally now turn to AI ...

A discussion with Talaya Dendy, a Minneapolis-based cancer doula, board-certified patient advocate and Hodgkin lymphoma thriver ...

Boston Globe reporter Mark Shanahan is best known for his daily column on entertainment and pop culture. Now, however, he’s dipping a toe into digital media with his new podcast, Mr. 80 Percent. In ...

breast cancer chemotherapy The Guardian reports Australian Women’s Weekly magazine standard medical treatment National Cancer Institute describes intraductal breast carcinoma (also known as ductal ...

MRA’s Melanoma Exchange Patient Forum, held in-person in Washington DC and virtually on February 25, 2026, brought together hundreds of melanoma patients, survivors, advocates, and their loved ones to ...

Located at the base of the neck and shaped like a butterfly, the thyroid gland plays an important role in regulating metabolism, body temperature, growth and body development by constantly releasing ...

SLNB, which involves surgical removal and analysis of a lymph node closest to the primary tumor, is the preferred method for axillary staging in early-stage breast cancer. However, accumulating ...

To that awkward greeting, Richard Wassersug, PhD, who has lived with prostate cancer over 25 years, crafted an apt answer—and a call to action.